Patent · US Active

Compounds and compositions for the inhibition of NAMPT

US11279687B2 · kind B2 · utility

2Cited by

21References

9Claims

0Family size

Assignees

Valo Health, Inc. · US
Genentech, Inc. · US

Inventors

Kenneth W. Bair · Chapel Hill, US
Timm R. Baumeister · Watertown, US
Alexandre Joseph Buckmelter · Superior, US
Karl H. Clodfelter · Watertown, US
Bingsong Han · Westwood, US
Jian Lin · Watertown, US
Dominic Reynolds · Stoneham, US
Chase C. Smith · Rutland, US
Zhongguo Wang · Lexington, US
Xiaozhang Zheng · Lexington, US
Po-Wai Yuen · Ann Arbor, US

Key dates

Filing date	Mar 20, 2020
Grant date	Mar 22, 2022
Priority date	—
Expiry date	Mar 20, 2040

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D471/04
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to compounds and compositions for the inhibition of NAMPT, their synthesis, applications and antidotes. An embodiment of the invention is the provision of a compound of Formula IIIA.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.